Australia's largest stock trading and investment forum Australia's #1 stock forum

PAR

0.00%

26.5¢ paradigm biopharmaceuticals limited..

Great post MozzYou are right of course, we shouldn't really look...

First 20 Last

Share
Profile

Follow
Nickporthcawl

1,555 Posts.

194

30/11/20

22:09

Post #: 49250446
Share

Originally posted by Mozzarc: ↑

Nick, no doubt we need some patience if you look too closely at the SP!

But to keep ME motivated to stay the course (let alone others) there is a lot on the horizon, not all of it is distant. We have some catalysts coming...

Most of us know them, but a few highlights...somewhat in chronological order but of course subject to change...

Evercore Bio Conference
FDA Type C feedback
R & D Day
Manuscript (Twins) - Peer review
JPM Morgan Conference

Then we will have the big ones:

IND - OA
IND - MPS VI

After that?
SAS - Patient Pay Program?
And of course in the background TGA Provisional Submission?
Sometime maybe towards end of next year we will also have the P2 MPS I read out (Adelaide)

More?
Twins next stage (Could be a regional deal? Could be a P3 Design)
Research Tie-up advancement

Background?
..Yes and while all of the above is enough to keep me going...there always looms (and it gets larger as we cross the IND's and are in the midst of P3 trials), the real possibility of a distribution deal.

I'm not longer bored. I also see the 'hike' you speak of coming one fine day, perhaps out of the blue.
I look forward to the day Pool_COO summons AF and I to launch-pad...it will come one day.

DYOR

Expand

Great post Mozz

You are right of course, we shouldn't really look at the SP daily but focus on the news flow and fundamentals

Cant see this being below $3 for much longer though!

PAR Price at posting: $2.96 Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

What's causing the cost-of-living crisis, and how to navigate it

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war